Quantitative Fluorescence Angiography With ICG for Perfusion Assessment During Surgery
NCT ID: NCT05489757
Last Updated: 2023-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
239 participants
INTERVENTIONAL
2022-02-16
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Quantitative fluorescence angiography with ICG (Q-ICG) could overcome these limitations. In Q-ICG the fluorescence signal is elaborated by a new computer quantification algorithm and translated into a fluorescence-time curve (FTC), from which several Q-ICG parameters and values can be extracted. Given the power of ICG in reflecting the perfusion of examined tissues, a new quantification algorithm has the potential to turn the subjective parameters derived from surgeon's perspective into objective numeric values.
The primary aim of this study is to evaluate which Q-ICG values provided by a new quantification algorithm correspond to subjective perfusion parameters usually evaluated by the surgeon in patients undergoing left colon, rectal or esophagogastric resections.
The secondary aim is to evaluate possible correlations between Q-ICG values provided by the quantification algorithm and perioperative outcomes.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SPY Portable Handheld Imaging (SPY-PHI) System with SPY-QP Software
Perfusion assessment with SPY Q-ICG system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and Female, Age \> 18 years
* Patients undergoing left colon, rectal or esophagogastric resections
* Patients with malignant or benign disease
* Minimally invasive or open approach surgery
Exclusion Criteria
* Limited sigmoid resection without ligation of the inferior mesenteric artery
* Known allergies, hypersensitivity or intolerance to indocyanine green (ICG) or iodine contrast agents,
* Patients with hyperthyroidism or benign thyroid tumor
* Acute or chronic kidney failure (stage ≥ 3)
* Pregnant or lactating women, or with a positive pregnancy test performed before surgery
* Any clinical condition for which, in the opinion of the investigator, participation would not be in the best interest of the patient or that could prevent, limit, or confound the protocol-specified assessments
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lorenzo Cinelli
Clinical Research Fellow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lorenzo Cinelli
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
154/INT/2021
Identifier Type: -
Identifier Source: org_study_id